Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 USD | +0.49% |
|
-1.84% | +61.92% |
06-02 | Transcript : Cullinan Therapeutics, Inc. - Special Call | |
06-01 | Cullinan Therapeutics, Inc. Announces Positive Initial Data from Pivotal Phase 2b Rezil1 Study of Zipalertinib | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CULLINAN THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +0.49% | -1.84% | +61.92% | +45.05% | - | 951M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- CGEM Stock
- Charts Cullinan Therapeutics, Inc.
- Relative Strength Chart